Keyphrases
Acute Myeloid Leukemia
100%
Cyclin-dependent Kinase 9 (CDK9)
100%
Mammalian Target of Rapamycin (mTOR)
60%
MLST8
60%
Mammalian Target of Rapamycin Signaling
40%
Xenograft
20%
Phosphorylation
20%
Scaffold Protein
20%
Binding Partners
20%
Novel Therapeutic Targets
20%
Leukemogenesis
20%
Survival Benefit
20%
Proteomic Analysis
20%
Antileukemic Activity
20%
Pharmacological Targeting
20%
Signaling Activation
20%
Malignant Phenotype
20%
Raptor
20%
RPS6
20%
LARP1
20%
Rictor
20%
SIN-1
20%
Messenger RNA Processing
20%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Mechanistic Target of Rapamycin
100%
Cyclin-Dependent Kinase 9
100%
Transcription
20%
RICTOR
20%
Proteomics
20%
RNA Translation
20%
Scaffold Protein
20%
Messenger RNA
20%
Neuroscience
Mammalian Target of Rapamycin
100%
Myeloid
100%
Cyclin Dependent Kinase 9
100%
In Vivo
20%
Amino Acid Activation
20%
In Vitro
20%
Proteomics
20%
Scaffold Protein
20%
Messenger RNA
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclin Dependent Kinase 9
100%
Acute Myeloid Leukemia
100%
Mammalian Target of Rapamycin
100%
Scaffold Protein
20%
Leukemogenesis
20%
Messenger RNA
20%